FRANKLIN LAKES, N.J., Nov. 30, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued the following statement regarding the U.S.

BD has turned to Mitsubishi Gas Chemical (MGC) to look into ways to improve the delivery of biologics, signing a letter of intent that positions it to assess its partner’s alternative to glass for ...

Becton Dickinson ($BDX) is buying California's Safety Syringes, a maker of anti-needlestick devices, looking to bolster its injectable offerings. BD didn't disclose ...

Becton, Dickinson and Company (BD) has announced an investment exceeding $35m to expand the manufacturing of BD PosiFlush prefilled flush syringes at its facility in Columbus, Nebraska, US. This ...

FRANKLIN LAKES, N.J., March 21, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company (BDX)), a leading global medical technology company, today issued the following statement regarding the March 19, ...

LE PONT-DE-CLAIX, France, Sept. 18, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced the commercial release of the BD Neopak™ ...

The Food and Drug Administration has posted a Class I notice about Becton Dickinson infusion pumps affected by compatibility issues with Cardinal Health Monoject syringes. Cardinal sent an urgent ...

Becton, Dickinson and Co. has announced it will acquire Safety Syringes, according to a news release. Safety Syringes, headquartered in Carlsbad, Calif., develops anti-needlestick devices for ...

FDA warns that compounded or repackaged drugs stored in certain syringes made by Becton-Dickinson may lose potency because of an interaction with the rubber stopper. FDA alerted healthcare ...

Medtech giant BD has announced plans to invest more than $35 million and add approximately 50 new jobs to expand prefilled flush syringe manufacturing at its Columbus, NE, facility. The investments ...